Arthritis News and Research

Latest Arthritis News and Research

Signaling molecules have different effects on key inhibitory protein

Signaling molecules have different effects on key inhibitory protein

Some religious groups seek health care for illegal immigrants

Some religious groups seek health care for illegal immigrants

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Center for Hip Pain and Preservation focuses on improved understanding of hip abnormalities

Center for Hip Pain and Preservation focuses on improved understanding of hip abnormalities

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

Drug carrier that cuts off blood supply to tumors

Drug carrier that cuts off blood supply to tumors

NIH to fund grants for epigenetic research

NIH to fund grants for epigenetic research

SI-BONE's summit to develop clinical diagnostic process for SI Joint pathology identification

SI-BONE's summit to develop clinical diagnostic process for SI Joint pathology identification

Genentech releases Phase III PRIMA study findings

Genentech releases Phase III PRIMA study findings

FDA Advisory Committee recommends marketing approval for Auxilium's XIAFLEX to treat Dupuytren's contracture

FDA Advisory Committee recommends marketing approval for Auxilium's XIAFLEX to treat Dupuytren's contracture

BioSpecifics Technologies' XIAFLEX receives marketing approval from FDA

BioSpecifics Technologies' XIAFLEX receives marketing approval from FDA

New technique found that may prevent vision loss

New technique found that may prevent vision loss

Amgen to present its four Phase 3 clinical trial results

Amgen to present its four Phase 3 clinical trial results

Medivir presented preclinical data from its cathepsin K inhibitor program at the ASBMR meeting

Medivir presented preclinical data from its cathepsin K inhibitor program at the ASBMR meeting

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Legislation grants improve research and employment initiatives in Indiana University medical campus

Legislation grants improve research and employment initiatives in Indiana University medical campus

Roche's peg-EPO product Mircera infringes Amgen patents

Roche's peg-EPO product Mircera infringes Amgen patents

PsoriasisDX Genetic Test for Psoriatic arthritis launched

PsoriasisDX Genetic Test for Psoriatic arthritis launched

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

Vivakor completes third-party validation testing of its VivaBlend nutraceutical product

Vivakor completes third-party validation testing of its VivaBlend nutraceutical product

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.